MacroGenics Inc (MGNX)
Drugs • Health Care
Percentage
Change
| Mar 14 | Mar 15 | Feb 16 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 22 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -67 | -75 | |||||||||||
Net Income | -67 | -75 | |||||||||||
Profit | -67 | -75 | |||||||||||
Net Income Continuing | -67 | -75 | |||||||||||
Income Tax Expense | -1 | 1 | |||||||||||
Pretax Income | -66 | -75 | |||||||||||
Total Non-operating Income | 45 | -2 | |||||||||||
Operating Income | -111 | -73 | |||||||||||
Total Revenue | 150 | 150 | |||||||||||
Total Costs and Expenses | -261 | -222 | |||||||||||
Cost of Revenue | -1 | 0 | |||||||||||
Operating Expenses | -260 | -186 | |||||||||||
Research and Development Expenses | -177 | -147 | |||||||||||
Selling, General & Administrative Expenses | -71 | -39 | |||||||||||
Other Operating Expenses | -11 | 0 |